Arrowhead Pharmaceuticals Inc (ARWR) Company Profile

Arrowhead Pharmaceuticals Inc Company Snapshot

Arrowhead Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arrowhead Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : AC Immune SA (2019 sales of $111.79 million of which 100% was Therapeutic and Diagnostic Products), Radius Health Inc ($173.32 million of which 100% was Drug Manufacturer), and Jounce Therapeutics Inc ($147.87 million of which 100% was Immunotherapy).

Sales Analysis. Sales increased substantially in 2019: During the year ended September of 2019, sales at Arrowhead Pharmaceuticals Inc were $168.80 million. This is an increase of 945.7% versus 2018, when the company's sales were $16.14 million.

Arrowhead Pharmaceuticals Inc

Stock Data:

Recent Stock Performance:

Current Price (10/16/2020): 49.38
(Figures in U.S. Dollars)

1 Week	7.2%	13 Weeks	14.6%

4 Weeks	0.7%	52 Weeks	37.4%

Arrowhead Pharmaceuticals Inc Key Data:

Ticker:	ARWR	Country:	United States

Exchanges:	NAS	Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2019 Sales	168,795,577 (Year Ending Jan 2020).	Employees:	134

Currency:	U.S. Dollars	Market Cap:	5,049,148,059

Fiscal Yr Ends:	September	Shares Outstanding:	102,250,872

Share Type:	Common	Closely Held Shares:	2,728,656

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.